Long-Term Kidney Function of COVID-19 Survivors: A Prospective Cohort Study

Background: Long COVID encompasses symptoms that persist >2 months. Its effects on kidney function remain poorly understood. We aimed to investigate the long-term kidney function of COVID-19 survivors. Methods: A prospective cohort of moderate and severe COVID-19 surviving patients was analyzed. Eligible patients were contacted at 6–9 months after hospital discharge. Kidney function at hospital admission, discharge, and follow-up was assessed by estimated glomerular filtration rate (eGFR; CKD-EPI serum creatinine race-free equation). Urinary albumin was evaluated at follow-up. Major Adverse Kidney Events (MAKE) at follow-up was defined as eGFR <60 ml/min/1.73 m2, eGFR decline ≥40% from discharge, or albuminuria (>30 mg/L). MAKE-associated factors were investigated by binary logistic regression. Results: We assessed 655 patients (55±14 years, 45% ≥60 years, 46% female, 50% black). At hospital admission, eGFR was 82.2 ml/min/1.73 m2 (IQR:49.3–103.5). During hospital stay (median 15 days), peak SCr was 1.52 (IQR:1.02–3.26), 67% were admitted to intensive care units, 46% required intubation, 79% had acute kidney injury (35% at admission; 43% during hospitalization), and 14% needed dialysis. At hospital discharge, eGFR was 92.3 (IQR:64.3–107.4). After 7.8±1.6 months of follow-up, 14% of the patients showed eGFR decline >40% (median -5.4%; IQR:-26.7 – 30.2), and 16% of the patients showed eGFR <60 ml/min/1.73 m2. MAKE was found in 39% of the patients. The factors independently associated with MAKE were older age (odds ratio [OR]=1.54, 95%CI:1.11–2.14) and peak SCr (OR=1.20, 95%CI:1.10–1.32). Conclusion: Long-term kidney dysfunction was found in a large proportion of COVID-19 survivors, suggesting that kidney long COVID might be a significant health problem. Older age and peak SCr during hospitalization were independent risk factors associated with MAKE. Funding: Government Support – Non-U.S.Figure 1. eGFR overtime stratified by follow-up kidney function

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024dk11798g
Citations
2
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Kidney Function of COVID-19 Survivors: A Prospective Cohort Study

Lia Marçal, Carlos Roberto Ribeiro de Carvalho, Heitor S. Ribeiro, Geraldo F. Busatto et al.
2 citations
Journal of the American Society of Nephrology
Liver Disease Diagnosis and Treatment
0.77
article

Long-Term Kidney Function of COVID-19 Survivors: A Prospective Cohort Study

Lia Marçal, Carlos Roberto Ribeiro de Carvalho, Heitor S. Ribeiro, Geraldo F. Busatto, Marcella Martins Frediani, Emmanuel A. Burdmann, Luís Yu, Guilherme P. Santa Catharina
article en
2 citations

Abstract

Background: Long COVID encompasses symptoms that persist >2 months. Its effects on kidney function remain poorly understood. We aimed to investigate the long-term kidney function of COVID-19 survivors. Methods: A prospective cohort of moderate and severe COVID-19 surviving patients was analyzed. Eligible patients were contacted at 6–9 months after hospital discharge. Kidney function at hospital admission, discharge, and follow-up was assessed by estimated glomerular filtration rate (eGFR; CKD-EPI serum creatinine race-free equation). Urinary albumin was evaluated at follow-up. Major Adverse Kidney Events (MAKE) at follow-up was defined as eGFR <60 ml/min/1.73 m2, eGFR decline ≥40% from discharge, or albuminuria (>30 mg/L). MAKE-associated factors were investigated by binary logistic regression. Results: We assessed 655 patients (55±14 years, 45% ≥60 years, 46% female, 50% black). At hospital admission, eGFR was 82.2 ml/min/1.73 m2 (IQR:49.3–103.5). During hospital stay (median 15 days), peak SCr was 1.52 (IQR:1.02–3.26), 67% were admitted to intensive care units, 46% required intubation, 79% had acute kidney injury (35% at admission; 43% during hospitalization), and 14% needed dialysis. At hospital discharge, eGFR was 92.3 (IQR:64.3–107.4). After 7.8±1.6 months of follow-up, 14% of the patients showed eGFR decline >40% (median -5.4%; IQR:-26.7 – 30.2), and 16% of the patients showed eGFR <60 ml/min/1.73 m2. MAKE was found in 39% of the patients. The factors independently associated with MAKE were older age (odds ratio [OR]=1.54, 95%CI:1.11–2.14) and peak SCr (OR=1.20, 95%CI:1.10–1.32). Conclusion: Long-term kidney dysfunction was found in a large proportion of COVID-19 survivors, suggesting that kidney long COVID might be a significant health problem. Older age and peak SCr during hospitalization were independent risk factors associated with MAKE. Funding: Government Support – Non-U.S.Figure 1. eGFR overtime stratified by follow-up kidney function

Journal of the American Society of NephrologyVol. 35(10S)
Universidade de São Paulo (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Fundação Faculdade de Medicina (BR)
Gender equality
Openalex Percentile: Top 25%
Liver Disease Diagnosis and Treatment
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.